0001209191-23-018561.txt : 20230314
0001209191-23-018561.hdr.sgml : 20230314
20230314174407
ACCESSION NUMBER: 0001209191-23-018561
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230310
FILED AS OF DATE: 20230314
DATE AS OF CHANGE: 20230314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morrow Phuong Khanh
CENTRAL INDEX KEY: 0001928989
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37923
FILM NUMBER: 23732266
MAIL ADDRESS:
STREET 1: C/O CRISPR THERAPEUTICS
STREET 2: 610 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CRISPR Therapeutics AG
CENTRAL INDEX KEY: 0001674416
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 473173478
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
BUSINESS PHONE: 6173154600
MAIL ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-10
0
0001674416
CRISPR Therapeutics AG
CRSP
0001928989
Morrow Phuong Khanh
C/O CRISPR THERAPEUTICS, INC.
105 W FIRST STREET
BOSTON
MA
02127
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
43.22
2023-03-10
4
A
0
44620
0.00
A
2033-03-10
Common Shares
44620
44620
D
Restricted Stock Units
2023-03-10
4
A
0
22000
0.00
A
Common Shares
22000
22000
D
This option was granted on March 10, 2023 with respect to 44,620 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 10, 2023.
Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
This restricted stock unit award was granted on March 10, 2023 with respect to 22,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027.
/s/ Elizabeth Ryland Waldinger, attorney-in-fact
2023-03-14